Fortis Advisors, LLC Organon & Co. Transaction History

Fortis Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$10.95 - $17.32 $42,836 - $67,755	-3,912 Reduced 96.76%	131 $1,000
Q1 2023 May 09, 2023	BUY	$21.42 - $32.08 $83,795 - $125,496	3,912 Added 2986.26%	4,043 $95,000
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $8,601 - $11,139	-300 Reduced 69.61%	131 $4,000
Q3 2021 Nov 23, 2021	SELL	$28.63 - $35.64 $178,364 - $222,037	-6,230 Reduced 93.53%	431 $14,000
Q3 2021 Nov 12, 2021	BUY	$28.63 - $35.64 $179,052 - $222,892	6,254 Added 1536.61%	6,661 $20,000
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $11,579 - $15,466	407 New	407 $12,000

793

204M

1.71M

870K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.72B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Fortis Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fortis Advisors, LLC with notifications on news.